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ABSTRACT
The Diels-Alder reaction between diene-modified oli-
gonucleotides and maleimide-derivatized peptides
afforded peptide–oligonucleotide conjugates with
high purity and yield. Synthesis of the reagents was
easily accomplished by on-column derivatization of
the corresponding peptides and oligonucleotides.
The cycloaddition reaction was carried out in mild
conditions, in aqueous solution at 37 C. The speed
of the reaction was found to vary depending on the
size of the reagents, but it can be completed in 8–10 h
by reacting the diene-oligonucleotide with a small
excess of maleimide-peptide.
INTRODUCTION
In the past three decades, chemists involved in the preparation
of synthetic oligonucleotide analogs suitable for use in
the control of gene expression have introduced modiﬁcations
in virtually every part of oligonucleotide chains [see, for
instance (1–3)].
Among such modiﬁcations, the covalent attachment of
peptides to oligonucleotides has received considerable
attention because of the potential applications of peptide–
oligonucleotide conjugates, such as the development of
more effective oligonucleotide-based technologies. Peptides
have been covalently linked to oligonucleotide chains for sev-
eral purposes: with the aim of preparing nucleases (4–6), for
the introduction of reporter groups (7), for the study of DNA–
protein interactions (8), to investigate the molecular require-
ments for enzyme activity (9), to evaluate how metals or
metal-based drugs behave when DNA and proteins are in
close proximity (10,11), to increase the speciﬁcity of RNA-
interacting oligonucleotides (12) and to facilitate the transport
of antisense oligonucleotides through cell membranes
(13–17). Linking peptides to oligonucleotides has also been
described as rendering oligonucleotides more resistant to
exonucleases (18–20), and, in the case of cationic peptides,
as accelerating duplex formation (21). Positively charged
and hydrophobic peptides stabilize short duplexes (22,23),
but their inﬂuence on the thermal stability of duplexes
with more than 15 bases is much weaker (12,24). Triplex
stabilization by appending cationic peptides has also been
described (25).
Since both peptides and oligonucleotides are biomolecules
extremely rich in functional groups, ﬁnding reaction condi-
tions that yield structurally deﬁned conjugates rather than
mixtures of products is far from being trivial. This problem
has been tackled either by protecting non-participating func-
tional groups, or by modifying the biomolecules with addi-
tional functional groups expected to drive the reaction as
desired (26,27) [see also references (28–30) for examples of
recent papers on the development of methodology for the
synthesis of peptide–oligonucleotide conjugates].
The Diels-Alder reaction is a very attractive methodology
for the conjugation of biomolecules, since it is fast and efﬁ-
cient in aqueous media (31–33) in addition to being chemose-
lective. It has been used, for instance, for the modiﬁcation of
peptides (34), to link covalently carbohydrates to proteins
(35), for the immobilization of oligonucleotides on glass
surfaces (36), and, most often, for the labelling of DNA
and RNA fragments with biotin or ﬂuoresceine derivatives
(37–42). The Diels-Alder approach, which involves a diene
and a dienophile not present in any biomolecule, allows
for a chemoselective reaction without the need for protec-
ting groups. Here, we describe the use of the Diels-Alder
cycloaddition in water for the preparation of peptide–
oligonucleotide conjugates incorporating all the nucleobases
and most trifunctional amino acids. These conjugates were
obtained by the reaction between an acyclic diene linked
to the oligonucleotide chain and a maleimide-derivatized
peptide (Figure 1).
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a-Fmoc-L-amino acids and resins for peptide synthesis were
obtained from Novabiochem (Fmoc ¼ 9-ﬂuorenylmethoxy-
carbonyl). Trifunctional Fmoc-amino acid derivatives used:
Arg(Pbf),Asn(Trt),Asp(OtBu),Gln(Trt),Glu(OtBu),His(Trt),
Lys(Boc), Ser(tBu), Thr(tBu) and Tyr(tBu) (Pbf ¼ 2,2,4,
6,7-pentamethyldihydrobenzofuran-5-sulfonyl, Trt ¼ trityl,
tBu ¼ tert-butyl, Boc ¼ tert-butoxycarbonyl). The 30-O-(2-
cyanoethyl)-N,N-diisopropylphosphoramidite derivatives of
DMT-dA
Bz, DMT-dC
Bz, DMT-dG
iBu and DMT-T, and 50-
DMT-nucleoside-LCAA-CPG (DMT ¼ 4,40-dimethoxytrityl,
Bz ¼ benzoyl, iBu ¼ isobutyryl, LCAA-CPG ¼ long chain
aminoalkyl controlled pore glass beads) were purchased from
theGlenResearchCorporation.CH2¼CH-CH¼CH-CH2-CH2-
O-P(OCNE)NiPr2 (CNE ¼ 2-cyanoethyl) was prepared by
phosphitylation of 3,5-hexadien-1-ol (43) as described previ-
ously (40). 3-Maleimidepropanoic acid was from Aldrich.
Solid-phase syntheses were performed manually in a polypro-
pylene syringe ﬁtted with a polyethylene disc (peptides), or
using the Expedite automatic DNA synthesizer from Applied
Biosystems (oligonucleotides).
Reversed-phase high-performance liquid chromatography
(HPLC) analyses were carried out on Kromasil C18 columns,
usinglineargradientsof0.045%TFAinH2Oand0.036%TFA
in ACN for peptide analyses (detection wavelength: 220 nm)
(TFA ¼ triﬂuoroacetic acid, ACN ¼ acetonitrile), and 0.01 or
0.05 M aq. ammonium acetate and ACN/H2O (1:1) for oligo-
nucleotide analyses (detection wavelength: 260 nm). Puriﬁca-
tion by HPLC was carried out either using the same analytical
Kromasil column (1 ml/min) or a PRP (Hamilton) column
(2 ml/min).
A [Vydac C18]-ﬁlled glass column (22 · 2 cm) was
used for medium pressure liquid chromatography (MPLC),
using aqueous and ACN solutions containing 0.1% TFA
in peptide puriﬁcation, and 0.05 M ammonium acetate and
1:1 ACN/H2O mixtures in oligonucleotide puriﬁcation.
Elution was carried out by connecting a piston pump to the
mixing chamber of a gradient-forming device and to the top
of the glass column. The mixing chamber of the gradient-
forming device was the ﬂask containing solvent A, which
was connected through a stopcock to the ﬂask containing
solvent B.
Sephadex G-25 was used for gel ﬁltration (elution with
0.05 M aq. ammonium acetate).
Matrix-assisted laser desorption ionization time-of-ﬂight
(MALDI-TOF) mass spectrometric analysis was carried out
using a Voyager-DERP (Applied Biosystems) instrument
and the following conditions: oligonucleotides and
conjugates: trihydroxyacetophenone/ammonium citrate, neg-
ative mode, linear (unless otherwise indicated); peptides: 2,5-
dihydroxybenzoic acid, positive mode, reﬂector. Calculated
monoisotopicmassvaluesforneutralcompounds areindicated
in all cases. The exact mass spectrometric characterization
data were obtained using an Agilent 1100 LC/MS-TOF. Elec-
trospray mass spectrometric analysis was carried out using a
Micromass ZQ instrument.
The amounts of isolated oligonucleotides and conjugates
were determined spectrophotometrically, and peptides
were quantiﬁed by amino acid analysis after acid hydrolysis
(6 M HCl for 1.5 h at 160 C).
Solution synthesis of diene-TT
T-30-O-Pac. To a solution of 2.0 g of 50-O-(4,40-dimethoxy-
trityl)-20-deoxythymidine (3.7 mmol) and 2.8 g of phenoxy-
acetic anhydride (9.8 mmol) in 50 ml of anh. THF was added
1.5 ml of pyridine (18.6 mmol), and the mixture was stirred
overnight (Pac ¼ phenoxyacetyl, THF ¼ tetrahydrofuran).
Removal of the solvent at reduced pressure afforded a yellow-
ish oil, which was dissolved in DCM (75 ml) and extracted
twice with a 10% aq. NaHCO3 solution (100 ml, 2·) (DCM ¼
dichloromethane). The aqueous phase was re-extracted with
50 ml of DCM, and the combined organic phases were dried
over anh. Na2SO4, ﬁltered and evaporated to dryness. The
resulting oil was redissolved in the minimum amount of
AcOEt and precipitated with cold hexanes. After centrifuga-
tion, 50-O-DMT-T-30-O-Pac was obtained as a white solid
(1.82 g, 73% yield). The fully protected thymidine derivative
(1.82 g, 2.7 mmol) was dissolved in an 8:2 DCM/MeOH
solution, and cooled in an ice bath. A solution of 2.28 g of
p-toluenesulfonic acid (12 mmol) in the same solvent was
added, and the mixture was stirred for 1 h at 0 C. The reaction
was quenched by addition of 100 ml of a 10% aq. NaHCO3
solution. The aqueous phase was extracted with DCM (60 ml),
and the combined organic phases were dried over anh.
Na2SO4, ﬁltered, and evaporated to dryness. The 30-protected
thymidine derivative was puriﬁed by silica gel column chro-
matography, eluting with DCM/AcOEt mixtures of increasing
polarity, and obtained as a white solid (415 mg, 42% yield).
Mp: 156–158 C; Rf (CH2Cl2): 0.37;
1H-NMR (200 MHz,
CDCl3), d (p.p.m.): 1.26 (s, 3H, CH3), 2.40 (m, 2H, H20
and H200), 3.93 (m, 2H, H50 and H500), 4.11 (m, 1H, H40),
4.69 (s, 2H, CH2(Pac)), 5.50 (d, 1H, H30,J¼ 8 Hz), 6.20
(t, 1H, H10,J ¼ 7.1 Hz), 6.90–7.30 (m, 5H, Ph), 7.50
(s, 1H, H6), 8.60 (s, 1H, NH); ES-MS, positive mode:
m/z 399.1163 [M+Na]
+ (calcd mass for C18H20N2O7Na:
376.1162, error: 0.069 p.p.m.).
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Figure 1. General scheme for the preparation of peptide–oligonucleotide conjugates by Diels-Alder reaction in water.
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(0.73 mmol) and 115 mg of sublimed tetrazole (1.64 mmol)
were coevaporated from anh. ACN (3·) and dissolved in 3 ml
of anh. ACN. To this solution was added a solution of 50-O-
DMT-T-30-O-P(OCNE)NiPr2 (1 g, 1.34 mmol) in 6 ml anh.
ACN with a cannula, and the mixture was stirred for 1.5 h. A
total of 1.5 ml of a 6.0 M solution of tBuOOH in decane was
added (9.0 mmol), and after 30 min stirring, the mixture was
diluted with 50 ml of DCM and extracted with a 2.5% aq.
NaHCO3 solution (50 ml, 2·) and brine (50 ml). The organic
solution was dried over anh. Na2SO4, ﬁltered, and evaporated
to dryness, which afforded a yellowish oil. The DMT group
was removed from the fully protected dimer as described
above, and T-P(O)(OCNE)-T-30-O-Pac was obtained as a
brownish solid after silica gel column chromatography
eluting with DCM and increasing amounts of MeOH
(1–8%) (115 mg, 22% yield). Rf (CH2Cl2/MeOH 93:7):
0.38;
1H-NMR (400 MHz, CDCl3), d (p.p.m.): 1.92 (s, 3H,
CH3), 1.96 (s, 3H, CH3), 2.44 (m, 2H, H20 and H200), 2.45
(m, 2H, H20 and H200), 2.79 (t, 2H, CH2-CH2-CN, J ¼
5.6 Hz), 3.88 (s, 2H, H50 and H500), 4.19 (s, 2H, H50 and H500),
4.24 (t, 2H, CH2-CH2-CN, J ¼ 5.6 Hz), 4.32 (m, 1H, H40),
4.37 (m, 1H, H40), 4.71 (s, 2H, CH2, phenoxyacetyl), 5.20
(m, 1H, H30), 5.50 (m, 1H, H30), 6.16 (t, 1H, H10,J¼ 7 Hz),
6.22 (t, 1H, H10,J¼ 7 Hz), 6.90–7.34 (m, 5H, Ph), 7.39 (s, 1H,
H6), 7.40 (s, 1H, H6), 8.00–8.15 (broad signal, NH);
31P-NMR
(101,2 MHz, CDCl3), d (p.p.m.):  3.38,  3.49; ES-MS, pos-
itive mode: m/z 734.2070 [M+H]
+ (calcd mass: for
C31H37N5O14P: 734.2069, error: 0.114 p.p.m.).
CH2¼CH-CH¼CH-CH2-CH2-O-p-T-p-T (diene-TT). The
reaction between CH2¼CH-CH¼CH-CH2-CH2-O-P(OCNE)
NiPr2 (160 mg, 0.54 mmol) and T-P(O)(OCNE)-T-30-O-Pac
(115 mg, 0.16 mmol) was carried out as described above for
the preparation of the protected TT-dimer using 3.4 equivalent
of diene-phosphoramidite with respect to the TT-dimer. After
the aqueous work-up, removal of the 2-cyanoethyl and phen-
oxyacetyl protecting groups was accomplished by reaction
with 8 ml of a conc. aq. ammonia solution (32%) for 3 h at
room temperature. After evaporation to dryness, the target
diene-TT dimer was puriﬁed by MPLC eluting with a gradient
from 0 to 100% of B (A: 0.05 M NH4AcO, B: [70% 0.05 M
NH4AcO + 30% (ACN/H2O 1:1, v/v)], 600 ml of each solv-
ent). After lyophilization, 47 mg of a slightly yellow solid,
pure as shown by HPLC analysis, were obtained (43% yield).
MALDI-TOF MS (reﬂector): m/z 704.78 [M-H]
  (calcd mass:
704.15); ES-MS, positive mode: m/z 707.1723 [M+H]
+ (calcd
mass: for C26H37N4O15P2: 707.1725, error: 0.312 p.p.m.);
anal. HPLC: linear gradient from 5 to 40% of B in 30 min,
tR 18.1 min.
Solid-phase synthesis of diene-oligonucleotides
Oligonucleotides were assembled on CPG at the 1 mmol-scale
following standard procedures (phosphite triester approach).
No changes in the synthesis cycle were made for the incorp-
oration of the diene-phosphoramidite. Final deprotection was
carried out by reaction with conc. aqueous ammonia, either
overnight at 55 C (diene derivatives of oligodeoxynucleotides
CATGGCT and GATCTAAAAGACTTT) or for 4 h at room
temperature (T8 and T15 derivatives).
Diene-CATGGCT. Puriﬁcation was accomplished by MPLC
eluting with a gradient from 0 to 100% of B (A: 0.05 M
NH4AcO, B: [70% 0.05 M NH4AcO + 30% (ACN/H2O
1:1, v/v)], 600 ml of each solvent). A total of 34% synthesis
and puriﬁcation yield; MALDI-TOF MS: m/z 2254.98 [M-H]
 
(calcd mass: 2255.80); anal. HPLC: linear gradient from 5 to
40% of B in 30 min, tR 17.0 min.
Diene-GATCTAAAAGACTTT. Puriﬁcation was accom-
plished by MPLC eluting with a gradient from 0 to 100% of
B (A: 0.05 M NH4AcO, B: [70% 0.05 M NH4AcO + 30%
(ACN/H2O 1:1, v/v)], 600 ml of each solvent). A total of 32%
synthesis and puriﬁcation yield; MALDI-TOF MS: m/z
4725.20 [M-H]
- (calcd mass: 4732.70); anal. HPLC: linear
gradient from 5 to 60% of B in 30 min, tR 13.9 min.
Diene-TTTTTTTT. Puriﬁcation was accomplished by MPLC
eluting with a gradient from 0 to 100% of B {A: [90% 0.05 M
NH4AcO + 10% (ACN/H2O 1:1, v/v)], B: [65% 0.05 M
NH4AcO + 35% (ACN/H2O 1:1, v/v)], 600 ml of each
solvent}. A total of 39% synthesis and puriﬁcation yield;
MALDI-TOF MS: m/z 2530.56 [M-H]
  (calcd mass:
2530.44); anal. HPLC: linear gradient from 10 to 40% of B
in 30 min, tR 18.4 min.
Diene-TTTTTTTTTTTTTTT. Puriﬁcation was accomplished by
MPLC eluting with a gradient from 0 to 100% of B (A: [90%
0.05 M NH4AcO + 10% (ACN/H2O 1:1, v/v)], B: [65%
0.05 M NH4AcO + 35% (ACN/H2O 1:1, v/v)], 600 ml of
each solvent). A total of 21% synthesis and puriﬁcation
yield; MALDI-TOF MS: m/z 4652.88 (calcd mass: 4658.76),
electrospray MS: m/z 4661.18 [M-H]
  (calcd average mass:
4661.04); anal. HPLC: linear gradient from 10 to 40% of B in
30 min, tR 18.0 min.
Synthesis of maleimide-peptide-NH2
All the amino acids of the peptide sequence were subsequently
coupled on a Rink amide p-methylbenzhydrylamine resin (44)
(100 mg, loading: 69 mmol NH2/mg) following the standard
procedures of solid-phase peptide synthesis (10 min treatment
with 20% piperidine in N,N-dimethylformamide and reaction
with 3 equivalent of Fmoc-amino acid and DCC for 1–1.5 h
were used for the deprotection and coupling steps, respect-
ively), with the addition of 3 equivalent of HOBt for the
incorporation of 3-maleimidepropanoic acid, and in all coup-
lings in the octapeptide assembly (DCC ¼ N,N0-dicyclohexyl-
carbodiimide, HOBt ¼ 1-hydroxybenzotriazole). Cleavage
and deprotection were effected by reaction with TFA/H2O
95:5 in the case of the dipeptides (30 min), and with a
TFA/H2O/TIS 90:5:5 mixture (5 h) in the case of the octapep-
tide (TIS ¼ triisopropylsilane). Most of the TFA was removed
by bubbling N2 into the solution, and the resulting residue was
either diluted with H2O and lyophilized (dipeptides) or poured
ontocoldethertoprecipitatethe targetmolecule(octapeptide).
Crude maleimide-octapeptide was obtained after centrifuga-
tion and solvent removal. All maleimide-peptides were puri-
ﬁed by MPLC eluting with a gradient from 0 to 100% of B (A:
0.1% TFA in H2O, B: [60% (0.1% TFA in H2O) + 40% (0.1%
TFA in ACN)], 600 ml of each solvent).
Maleimide-Ala-Gly-NH2. A total of 27% synthesis and
puriﬁcation yield; MALDI-TOF MS: m/z 297.08 [M+H]
+
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1.05; anal. HPLC: linear gradient from 0 to 50% of B in 30
min, tR 10.1 min.
Maleimide-Asp-Gly-NH2. A total of 9% synthesis and puri-
ﬁcation yield; MALDI-TOF MS: m/z 340.91 [M+H]
+ (calcd
mass: 340.41); amino acid composition: Asp 0.87, Gly 1.12;
anal. HPLC: linear gradient from 0 to 50% of B in 30 min, tR
9.7 min.
Maleimide-Lys-Gly-NH2. A total of 41% synthesis and puri-
ﬁcation yield; MALDI-TOF MS: m/z 354.26 [M+H]
+ (calcd
mass: 353.58); amino acid composition: Gly 1.10, Lys 0.90;
anal. HPLC: linear gradient from 0 to 50% of B in 30 min, tR
9.5 min.
Maleimide-Ser-Gly-NH2. A total of 42% synthesis and puri-
ﬁcation yield; MALDI-TOF MS: m/z 312.96 [M+H]
+ (calcd
mass: 312.42); amino acid composition: Ser 0.87, Gly 0.95;
anal. HPLC: linear gradient from 0 to 50% of B in 30 min, tR
9.1 min.
Maleimide-Gly-Thr-Ser-Lys-Leu-Asn-Tyr-Leu-NH2. A total
of 22% synthesis and puriﬁcation yield; MALDI-TOF MS:
m/z 1044.95 [M+H]
+ (calcd mass: 1046.15); amino acid
composition: Asp 0.96, Thr 0.75, Ser 0.99, Gly 1.22, Leu
2.32, Tyr 0.81, Lys 0.95; anal. HPLC: linear gradient from
0 to 50% of B in 30 min, tR 20.8 min.
Synthesis of maleimide-peptide-OH
The peptide was assembled on a 2-chlorotrityl chloride resin
(45) (360 mg, loading: 1.49 mmol Cl/mg). To prepare the
Fmoc-Ala-resin, the solid matrix was treated with a mixture
of Fmoc-Ala-OH (0.6 equivalent 100.2 mg) and N-ethyldiiso-
propylamine (5 equivalent 456 ml) for 45 min, and the remain-
ing reactive groups were capped by reaction with 400 mlo f
methanol. Deprotection of an aliquot of Fmoc-Ala-resin and
quantiﬁcation of the resulting 9-ﬂuorenylmethylpiperidine
showed that the loading was 0.63 mmol Fmoc/mg. The remain-
ing amino acids were incorporated using standard solid-phase
procedures (DIPC/HOBt-mediated couplings, DIPC ¼ N,N0-
diisopropylcarbodiimide).Thepeptide-resin bondwas cleaved
by reaction with a TFA/EDT/DCM (EDT ¼ 1,2-ethane-
dithiol) 1:1:98 mixture (5 · 30 s treatment), and amino acid
side chains were deprotected by adding a 2.5:2.5:2.5:1:91.5
thioanisole/H2O/EDT/TIS/TFA mixture to the resulting ﬁl-
trate (4.5 h, r. t.). Most of the TFA was removed by bubbling
N2 into the solution, and the resulting residue was poured onto
cold ether to precipitate the target maleimide-peptide. Puri-
ﬁcation was accomplished by MPLC eluting with a gradient
from 0 to 100% of B (A: [85% (0.1% TFA in H2O) + 15%
(0.1% TFA in ACN)], B: [55% (0.1% TFA in a total of
H2O) + 45% (0.1% TFA in ACN)], 600 ml of each solvent).
Maleimide-Lys-Glu-Thr-Ala-Ala-Ala-Lys-Phe-Glu-Arg-Gln-
His-Met-Asp-Ser-Ser-Thr-Ser-Ala-Ala-OH: 25% yield; MALDI-
TOF MS: m/z 2316.98 [M+H]
+ (calcd mass: 2316.04); amino
acid analysis after acid hydrolysis: Asp 1.07, Thr 1.95, Ser 2.84,
Glu 3.15, Ala 4.97, Met 0.97, Phe 1.08, His 1.15, Lys 1.97, Arg
1.15; anal. HPLC: linear gradient from 10 to 40% of B in 30 min,
tR 16.7 min.
Diels-Alder conjugation reactions
Reaction between diene-TT and maleimide-dipeptides. Diene-
TT and each of the maleimide-peptides were dissolved in
water and mixed to give 1 mM solutions containing a 1:1
molar ratio of the reagents (35 nmol). The reaction mixtures
were stirred at 37 C, and the progress of the reaction was
monitored by HPLC. A total of 90–95% conjugate was formed
in reaction times ranging between 4 and 14 h, as assessed from
the relative areas of the diene-dinucleotide and the conjugate
on the HPLC proﬁle. Two main products, corresponding to the
two diastereomeric forms of the target conjugate, were formed
in all cases, and showed different retention times upon HPLC
analysis (Figure 2A). For MALDI-TOF MS characterization
(products isolated by HPLC), see Table 1.
Anal. HPLC: linear gradient from 5 to 40% of B in 30 min,
tR: 15.1 and 15.5 min (TT-Ala-Gly conjugate), 12.5 and 12.9
min (TT-Asp-Gly conjugate), 15.6 and 16.0 (TT-Lys-Gly con-
jugate), 14.5 and 15.0 (TT-Ser-Gly conjugate).
The reaction between diene-TT and maleimide-Ser-Gly-
NH2 was repeated at the mmol-scale (2.9 mmol diene +
4.3 mmol dienophile, peptide/oligonucleotide molar ratio
1:1.5, diene-oligonucleotide concentration in the reaction
medium: 1.9 mM, maleimide-peptide concentration: 2.8 mM,
24 h), and the conjugate was isolated by HPLC eluting with a
gradient from 5 to 45% of B in 30 min (A: 0.01 M NH4AcO,
B: ACN/H2O 1:1, Kromasil C18 column). Conjugation and
puriﬁcation yield: 60%.
Reaction between maleimide-GTSKLNYL-NH2 and larger
diene-oligonucleotides. The cycloaddition reaction was also
carried out in water at 37 C, and monitored by HPLC and
MALDI-TOF MS. The molar ratio and reaction time were
adjusted in each case depending on the kinetics of the process.
The two conjugates were puriﬁed by HPLC and characterized
by mass spectrometry (Table 1).
Maleimide-GTSKLNYL-NH2 + diene-CATGGCT. 5.7 nmol
maleimide-peptide + 2.8 nmol diene-oligonucleotide, 2:1
Table 1. Mass spectrometric characterization data of the synthesized conjugates
Conjugate: MALDI-TOF MS
Peptide Oligonucleotide Found [M-H]
  Calcd M
AG-NH2 TT 1000.10 1000.58
KG-NH2 TT 1045.43 1044.56
SG-NH2 TT 1057.02 1057.63
DG-NH2 TT 1015.92 1016.57
GTSKLNYL-NH2 CATGGCT 3297.97 3301.13
GTSKLNYL-NH2 GATCTAAAAGACTTT 5776.62 5778.85
KETAAAKFERQHMDSSTSAA-OH TTTTTTTT 4842.21 4847.89
KETAAAKFERQHMDSSTSAA-OH TTTTTTTTTTTTTTT 6968.32 6974.80
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medium: 0.05 mM, 70% conjugation yield in 2.5 h (HPLC
analysis, Figure 2B). Anal. HPLC: linear gradient from 5 to
40% of B in 30 min, tR 26.9 min.
Maleimide-GTSKLNYL-NH2 + diene-GATCTAAAAGA-
CTTT. 3.0 nmol maleimide-peptide + 1.5 nmol diene-
oligonucleotide, 2:1 ratio, diene-oligonucleotide concentra-
tion in the reaction medium: 0.05 mM, 72% conjugation
yield in 6 h [HPLC analysis, Figure 2C, (a)]; 7.7 nmol maleim-
ide-peptide + 1.5 nmol diene-oligonucleotide, 5:1 ratio,
diene-oligonucleotide concentration in the reaction medium:
0.05 mM, >95% conjugation yield in 1 h [HPLC analysis,
Figure 2C, (b)]. Anal. HPLC: linear gradient from 5 to 60%
of B in 30 min, tR 17.6 min.
Maleimide-KETAAAKFERQHMDSSTSAA-OH + diene-T8.
The cycloaddition reaction between equimolar amounts of the
two reagents (55 nmol, 0.03 mM) was carried out in water at
37 C, and monitored by HPLC and MALDI-TOF MS: 80%
conjugation yield in 4 h, >95% conjugation yield after 20 h
[HPLC analysis, Figure 2D, (a)].
The reaction between maleimide-KETAAAKFERQHMD-
SSTSAA-OH and diene-T8 was repeated two more times at a
higher scale, using 1:1 molar ratios of peptide and oligonuc-
leotide, and the mixture analyzed by HPLC only after 20 h.
Since the conversion of diene-oligonucleotide to peptide–
oligonucleotide conjugate after that time was not quantitative,
an amount of maleimide-peptide equimolar to the amount of
unreacted diene-oligonucleotide was added, and the mixture
was left to react for a further 4 h. The reaction mixture was
lyophilized, and the target conjugate was isolated, in all cases,
after gel ﬁltration through Sephadex G-25. The following
results were obtained:
Second assay: 156 nmol-scale, 0.08 mM, 94% conjugation
yield after 20 h [HPLC analysis, Figure 2D, (b)]. Puriﬁcation:
gel ﬁltration. Conjugation and puriﬁcation yield: 59%.
Third assay: 110 nmol-scale, 0.05 mM, 90% conjugation
yield after 20 h [HPLC analysis, Figure 2D, (c)]. Puriﬁcation:
gel ﬁltration. Conjugation and puriﬁcation yield: 65%.
Anal. HPLC: linear gradient from 10 to 40% of B in 30 min,
tR 19.7 min. For mass spectrometric characterization, see
Table 1.
Maleimide-KETAAAKFERQHMDSSTSAA-OH + diene-T15.
Equimolar amounts (190 nmol) of the two reagents were
mixed in water (0.18 mM) and stirred at 37 C. The conjuga-
tion yield after 8 h was 56% [HPLC analysis, Figure 2E, (a)].
An amount of maleimide-peptide equimolar to the amount of
unreacted diene-oligonucleotide was added, and the mixture
was left to react for a further 8 h [Figure 2E, (b)]. The target
conjugate was obtained after puriﬁcation by gel ﬁltration.
Some fractions required additional repuriﬁcation to remove
small amounts of accompanying diene-oligonucleotide
(HPLC, PRP column, linear gradient from 15 to 35% of B
in 30 min, A: 0.05 M NH4AcO, B: ACN/H2O 1:1, 2 ml/min).
Conjugation and puriﬁcation yield: 62%. Anal. HPLC: linear
gradient from 10 to 40% of B in 30 min, tR 19.3 min. For mass
spectrometric characterization, see Table 1.
RESULTS AND DISCUSSION
As stated above, the goal of this study was to prepare peptide–
oligonucleotide conjugates using the Diels-Alder cycloaddi-
tion. The target conjugates were easily obtained by reaction
between diene-oligonucleotides and maleimide-peptides. This
Figure 2. Reversed-phase HPLC traces of the conjugation reactions (d, diene-
oligonucleotide; cj, conjugate). (A) maleimide-dipeptide-NH2 + diene-TT 1:1
after 4 h (the N-terminalamino acid of the dipeptide is indicatedon top of each
profile);(B)maleimide-GTSKLNYL-NH2 + diene-CATGGCT2:1after2.5h;
(C)maleimide-GTSKLNYL-NH2 + diene-GATCTAAAAGACTTT,2:1after
6 h (a) and 5:1 after 1 h (b); (D) maleimide-KETAAAKFERQHMDSSTSAA-
OH + diene-TTTTTTTT 1:1 after 20 h, first (a), second (b) and third (c) assay
(see Materials and Methods); (E) maleimide-KETAAAKFERQHMDSST-
SAA-OH + diene-TTTTTTTTTTTTTTT 1:1 after 20 h (a), and 8 h later
after having added the amount of peptide equivalent to that of unreacted
oligonucleotide (b).
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oligonucleotides and diene-peptides, since the maleimide moi-
ety is not stable to the ammonia treatment used for the ﬁnal
deprotection of oligonucleotides (46), and the diene would not
resist the acidic conditions in which peptide permanent pro-
tecting groups are removed. In all cases, derivatization was
carried out after chain assembly following standard protocols,
thus yielding 50-modiﬁed oligonucleotides and peptides with
the maleimide group linked to the N-terminal.
Several peptides and oligonucleotides with different com-
position and length were synthesized for this study (Table 1).
This allowed a variety of conjugates to be obtained, from
dipeptide-dinucleotide conjugates to conjugates incorporating
20mer peptides and 15mer oligonucleotides.
Peptide chains were assembled by solid-phase synthesis
using Fmoc/tBu-protected amino acid derivatives (47,48).
The commercially available 3-maleimidepropionic acid was
coupled onto the N-terminal of the immobilized peptide
chains. Peptide elongation on a Rink amide resin (44) afforded
maleimide-peptides with a C-terminal carboxamide, and the
2-chlorotrityl chloride resin (45) was used to obtain the
maleimide-peptide-OH. Deprotection of the immobilized
maleimide-peptides was carried out by treatment with TFA
(Figure 3) in the presence of the appropriate scavengers.
Maleimide-peptides were isolated by medium pressure liquid
chromatography and characterized by MALDI-TOF MS and
amino acid analysis.
The diene-derivatized TT dinucleotide was synthesized
in solution at the milligram-scale (Figure 4) (see Materials
and Methods for details), to obtain the amount of material
required for the preliminary conjugation assays with
the different maleimide-dipeptides. The other diene-
oligonucleotides were assembled on controlled pore glass
beads using standard phosphite triester methodology (49).
After the subsequent incorporation of the different
nucleosides, the phosphoramidite derivative of 3,5-
hexadiene-1-ol, previously prepared following described pro-
cedures (43,40), was coupled onto the 50 end (Figure 5).
Deprotection of diene-oligonucleotides was accomplished
by treatment with conc. aq. ammonia, at room temperature
for thymidine-containing chains, and at 55 C for oligonuc-
leotides incorporating the four nucleobases. HPLC and
mass spectrometric analysis of the diene-oligonucleotide
crudes showed that no measurable side reactions took place
upon incorporation of the phosphoramidite-derivatized 3,5-
hexadien-1-ol ontothe oligonucleotidechains,which indicates
that the diene group remains stable to oxidation with either
tBuOOH or aq. iodine. Diene-oligonucleotides were puriﬁed
by medium pressure liquid chromatography. Characteriza-
tionon was carried out by MALDI-TOF mass spectrometric
analysis, and purity was conﬁrmed by reversed-phase HPLC.
Although it is generally observed that longer oligonucleotide
chains have higher retention times, the retention time of diene-
TT was higher than that of diene-CATGGCT, and diene-T8
and diene-T15 had virtually the same retention time (see
Materials and Methods for details). This is probably related
to the presence of the hydrophobic diene substituent, whose
speciﬁc contribution to the chromatographic behavior of
the molecule is higher in the shortest diene-modiﬁed
oligonucleotides.
The Diels-Alder conjugation reaction was carried out
simply by mixing aqueous solutions of the diene-modiﬁed
oligonucleotide and maleimide-derivatized peptide, and stir-
ringthe resulting solution at37 C. Theprogressof the reaction
was monitored by reversed-phase HPLC (see Figure 2) and
MALDI-TOF mass spectrometry (analysis in the positive
mode may allow detection of maleimide–peptide in the
reaction mixture, but the mass spectrometric analysis is
usually conducted in the negative mode to allow detection
of diene-oligonucleotides and conjugates). The target
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and were easily isolated after gel ﬁltration through Sephadex
G-25 or reversed-phase HPLC. The conjugate structure was
conﬁrmed by MALDI-TOF mass spectrometric analysis
(Table 1).
The ﬁrst assays were carried out with the maleimide-
dipeptides and diene-TT (1:1 molar ratio). The reaction was
clean and fast in a few hours, as shown by HPLC analysis at
different reaction times. The four crudes contained two main
products (Figure 2A), which were isolated by HPLC and char-
acterized by MALDI-TOF MS. In all cases, the two products
had the same mass, that of a Diels-Alder adduct. Only the
diastereomers of these small conjugates could be separated by
HPLC, but not those of the larger ones (Figure 2B–E). We
surmise that these products are the two diastereomeric
conjugates resulting from the endo addition, which is usually
preferred over the exo. Detailed structural analysis of the
stereochemistry of these adducts is beyond the scope of
this paper. Both diastereomeric products can be useful for
biological applications.
It was also observed that the kinetics of the reaction
depended on the nature of the peptide, the order of reactivity
being KG>SG>AG>>DG (see HPLC traces after 4 h in
Figure 2A). These data indicate that the reaction rate increases
when favourable interactions between the two moieties, such
as those between the negatively charged oligonucleotide and a
positively charged peptide, can be established. The polar
hydroxyl group of the serine side chain also had a positive
effect, and the slowest reaction rate was found when two
negatively charged chains were brought together into the
same conjugate.
The second set of experiments involved an octapeptide
(maleimide-GTSKLNYL-NH2) and two oligonucleotides con-
taining the four nucleobases (diene-CATGGCT and diene-
GATCTAAAAGACTTT). These conjugations were carried
out using 2:1 peptide/oligonucleotide ratios. The HPLC
monitoring of these experiments showed that, as expected,
the rate of the reaction varied inversely with the size of the
diene reagent. A total of 70% conjugation yield was achieved
in2.5hwhenthe dienewaslinkedtothe7meroligonucleotide,
and in 6 h in the case of the 15mer oligonucleotide (Figure 2B
and C). The reaction between maleimide-GTSKLNYL-NH2
and diene-GATCTAAAAGACTTT was nearly quantitative in
1.5 h when a 5:1 peptide/oligonucleotide ratio was used.
The last group of experiments was performed with a 20mer
peptide (maleimide-KETAAAKFERQHMDSSTSAA-OH)
and two oligothymidines, diene-T8 and diene-T15. To evaluate
whetherlargeconjugatescouldbeobtainedingoodyieldswith
the lowest cost in reagents, the diene and the dienophile were
reacted in 1:1 molar ratio. The HPLC analysis of these reac-
tions showed that the conjugation process was not complete in
20–24 h, the reaction rate, again, showing an inverse depend-
ence on the reagents’ size (see details in Materials and
Methods). One way to drive these reactions to completion
was to increase the reaction time. However, it has been sug-
gested that undesired reactions between the free amines of the
amino acid side chains and the maleimide group of the peptide
moiety may take place at prolonged reaction times (50). More-
over, although this side reaction is faster in basic conditions,
some maleimide can be lost by hydrolysis (51). Therefore,
extending the reaction time over a period of days did not
seem the best choice, and we decided to add the required
extra amount of fresh maleimide-peptide (equimolar amount
with respect to unreacted oligonucleotide, as assessed by
HPLC analysis). A further 4 h was enough to complete the
conjugation process for the diene-T8, and 8 h in the case of
diene-T15.
The reaction between the 20mer peptide and diene-T8 was
repeated three times. The HPLC analysis after 20 h showed
that either the diene-oligonucleotide had been consumed, or
that the crude contained some 5–10% of unreacted diene. As
stated above, in all cases the reaction was completed in 4 h
after the required amount of peptide was added. These results
show the reproducibility of the method.
The cycloaddition reaction between two diene moieties was
not detected in any case. This is as expected, since the energy
of activation of this process is much higher, and hence this
reaction is much slower than the cycloaddition between the
diene and the maleimide groups.
In summary, the results presented here demonstrate the
utility of the Diels-Alder reaction for the easy, side-reaction
free preparation of peptide–oligonucleotide conjugates under
mild conditions. Diene-oligonucleotides and maleimide-
peptides can be easily prepared using standard solid-phase
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fast and chemoselective, and they allow the straightforward
synthesis of large peptide–oligonucleotide conjugates, con-
taining any nucleoside or trifunctional amino acid, which
are otherwise difﬁcult to obtain (26,27).
Certain adjustments in the methodology described here will
be required if cysteine is to be included in the peptide
sequence. The reaction between free thiols and maleimide
groups, which has been exploited for the preparation of
peptide–oligonucleotide conjugates (26), may compete with
the desired Diels-Alder cycloaddition, yielding side products
in which peptide chains are linked to each other as a result of
Michael additions. Furthermore, the thiols of two peptide
molecules may react to give disulﬁde-linked peptide dimers.
To avert the production of complex mixtures during conjuga-
tion, we intend to carry outthe cycloaddition using maleimide-
peptides with a protected cysteine residue, and to unmask the
thiol group after the conjugation has taken place.
Work is in progress to extend the use of the Diels-Alder
reaction for the preparation of different types of bioconju-
gates, including cysteine-containing peptide–oligonucleotide
hybrids.
ACKNOWLEDGEMENTS
Thiswork was supported by funds from the Spanish Ministerio
de Educacio ´n y Ciencia (grants BQU-2001-3693-C02-01 and
CTQ-2004-8275-C02-01) and the Generalitat de Catalunya
(2005SGR-693 and Centre de Refere `ncia de Biotecnologia).
Funding to pay the Open Access publication charges for this
article was provided by grant CTQ-2004-8275-C02-01.
Conflict of interest statement. None declared.
REFERENCES
1. Venkatesan,N., Kim,S.J. and Kim,B.H. (2003) Novel phosphoramidite
building blocks in synthesis and applications toward modified
oligonucleotides. Curr. Med. Chem., 10, 1973–1991.
2. Kurreck,J. (2003) Antisense technologies. Improvements through novel
chemical modifications. Eur. J. Biochem., 270, 1628–1644.
3. Leumann,C.J. (2002) DNA Analogues: from supramolecular
principles to biological properties. Bioorg. Med. Chem.,
10, 841–854.
4. Bashkin,J.K., Gard,J.K. and Modak,A.S. (1990) Synthesis and
characterization of nucleoside peptides: toward chemical ribonucleases.
1. J. Org. Chem, 55, 5125–5132.
5. Hovinen,J., Guzaev,A., Azhayeva,E., Azhayev,A. and Lo ¨nnberg,H.
(1995) Imidazole tethered oligodeoxyribonucleotides: synthesis and
RNA cleaving activity. J. Org. Chem., 60, 2205–2209.
6. Mironova,N.L., Pyshnyi,D.V., Ivanova,E.M., Zenkova,M.A., Gross,H.
andVlassov,V.V.(2004)Covalentlyattachedoligodeoxyribonucleotides
induceRNaseactivityofashortpeptideandmodulateitsbasespecificity.
Nucleic Acids Res., 32, 1928–1936.
7. Tong,G., Lawlor,J.M., Tregear,G.W. and Haralambidis,J. (1993) The
synthesis of oligonucleotide-polyamide conjugate molecules suitable as
PCR primers. J. Org. Chem., 58, 2223–2231.
8. Go ´mez-Pinto,I., Marcha ´n,V., Gago,F., Grandas,A. and Gonza ´lez,C.
(2003) Solution structure and stability of tryptophan-containing
nucleopeptide duplexes. ChemBioChem, 4, 40–49.
9. Debe ´thune,L., Kohlhagen,G., Grandas,A. and Pommier,Y. (2002)
Processing of nucleopeptides mimicking the topoisomerase I-DNA
covalent complex by tyrosyl-DNA phosphodiesterase. Nucleic Acids
Res., 30, 1198–1204.
10. Civitello,E.R., Leniek,R.G., Hossler,K.A., Haebe,K. and Stearns,D.M.
(2001) Synthesis of peptide–oligonucleotide conjugates for chromium
coordination. Bioconjug. Chem., 12, 459–463.
11. Marcha ´n,V., Pedroso,E. and Grandas,A.(2004) Insightsinto the reaction
oftransplatinwithDNAandproteins:methionine-mediatedformationof
histidine-guanine trans-Pt(NH3)2 cross-links. Chem. Eur. J., 10,
5369–5375.
12. Nelson,M.H., Stein,D.A., Kroeker,A.D., Hatlevig,S.A., Iversen,P.L. and
Moulton,H.M. (2005) Arginine-rich peptide conjugation to morpholino
oligomers:effectsonantisenseactivityandspecificity.Bioconjug.Chem.,
16, 959–966.
O
BPr
O
O
P
CNEO
O O
O
BPr
O
P O
O
CNEO
n
O
B
O
O
P
O
O O
O
B
O
P O
O
O
H
n
O
BPr
O
O
P
CNEO
O O
O
BPr
O
H
n
b
c
HO
O
BPr
O
a
BPr = ABz, CBz, GiBu, T
B = A, C, G, T
CPG
CPG CPG
Figure 5. Solid-phase synthesis of diene-oligonucleotides: (a) oligonucleotide assembly using standard 30-phosphoramidite nucleoside derivatives; (b) tetrazole-
mediated coupling of CH2¼CH-CH¼CH-CH2-CH2-O-P(OCNE)NiPr2, followed by capping and oxidation (aq. I2); (c) final deprotection with conc. aq. ammonia.
e24 Nucleic Acids Research, 2006, Vol. 34, No. 3 PAGE 8 OF 913. Bongartz,J.-P., Aubertin,A.-M., Milhaud,P. and Lebleu,B. (1994)
Improvedbiologicalactivityofantisenseoligonucleotidesconjugatedtoa
fusogenic peptide. Nucleic Acids Res., 22, 4681–4688.
14. Fischer,P.M., Krausz,E. and Lane,D.P. (2001) Cellular delivery of
impermeable effector molecules in the form of conjugates with peptides
capable of mediating membrane translocation. Bioconjug. Chem., 12,
825–841.
15. Astriab-Fisher,A., Sergueev,D., Fisher,M., Shaw,B.R. and Juliano,R.L.
(2002) Conjugates of antisense oligonucleotides with the Tat and
antennapedia cell-penetrating peptides: Effects on cellular uptake,
binding to target sequences, and biologic actions. Pharm. Res., 19,
744–754.
16. Gait,M.J. (2003) Peptide-mediated cellular delivery of antisense
oligonucleotides and their analogues. Cell. Mol. Life Sci., 60, 844–853.
17. Rogers,F.A., Manoharan,M., Rabonovitch,P., Ward,D.C. and
Glazer,P.M. (2004) Peptide conjugates for chromosomal gene targeting
by triplex-forming oligonucleotides. Nucleic Acids Res., 32, 6595–6604.
18. Haralambidis,J., Duncan,L., Angus,K. and Tregear,G.W. (1990) The
synthesis of polyamide-oligonucleotide conjugate molecules. Nucleic
Acids Res., 18, 493–499.
19. Juby,C.D., Richardson,C.D. and Brousseau,R. (1991) Facile preparation
of30oligonucleotide-peptideconjugates.TetrahedronLett.,32,879–882.
20. Robles,J., Maseda,M., Beltra ´n,M., Concernau,M., Pedroso,E.
and Grandas,A. (1997) Synthesis and enzymatic stability of
phosphodiester-linked peptide–oligonucleotide hybrids. Bioconjug.
Chem., 8, 785–788.
21. Corey,D.R. (1995) 48000-fold acceleration of hybridization by
chemically modified oligonucleotides. J. Am. Chem. Soc., 117,
9373–9374.
22. Harrison,J.G. and Balasubramanian,S. (1998) Synthesis and
hybridization analysis of a small library of peptide–oligonucleotide
conjugates. Nucleic Acids Res., 26, 3136–3145.
23. Marcha ´n,V., Debe ´thune,L., Pedroso,E. and Grandas,A. (2004)
Stabilization of DNA duplexes by covalently-linked peptides.
Tetrahedron, 60, 5461–5469.
24. Winkler,J.,Urban,E.andNoe,C.R.(2005)Oligonucleotidesconjugatedto
short lysine chains. Bioconjug. Chem., 16, 1038–1044.
25. Tung,C.-H., Breslauer,K.J. and Stein,S. (1996) Stabilization of DNA
triple-helix formation by appended cationic peptides. Bioconjug. Chem.,
7, 529–531.
26. Zubin,E.M.,Romanova,E.A.andOretskaya,T.S.(2002)Modernmethods
for the synthesis of peptide–oligonucleotide conjugates. Russ. Chem.
Rev., 71, 239–264.
27. Zatsepin,T.S., Stetsenko,D.A., Gait,M.J. and Oretskaya,T.S. (2005) Use
of carbonyl group addition-elimination reactions for synthesis of nucleic
acid conjugates. Bioconjug. Chem., 16, 471–489.
28. Zaramella,S., Yeheskiely,E. and Stro ¨mberg,R. (2004) A method for
solid-phase synthesis of oligonucleotide 50-peptide conjugates using
acid-labile a-amino protections. J. Am. Chem. Soc., 126, 14029–14035.
29. Turner,J., Arzumanov,A.A. and Gait,M.J. (2005) Synthesis, cellular
uptake and HIV-1 Tat-dependent trans-activation inhibition activity of
oligonucleotide analogues disulphide-conjugated to cell-penetrating
peptides. Nucleic Acids Res., 33, 27–42.
30. Ocampo,S.M., Albericio,F., Ferna ´ndez,I., Vilaseca,M. and Eritja,R.
(2005)Astraightforwardsynthesisof50 oligonucleotideconjugatesusing
N
a-Fmoc-protected amino acids. Org. Lett., 7, 4349–4352.
31. Rideout,D.C. and Breslow,R. (1980) Hydrophobic acceleration of
Diels-Alder reactions. J. Am. Chem. Soc., 102, 7816–7817.
32. Li,C.J. (2005) Organic reactions in aqueous media with a focus on
carbon–carbon bond formations. A decade update. Chem. Rev., 105,
3095–3165.
33. Narayan,S., Muldoon,J., Finn,M.G., Fokin,V.V., Kolb,H.C. and
Sharpless,K.B. (2005) ‘On water’: unique reactivity of organic
compounds in aqueous suspension. Angew. Chem. Int. Ed., 44,
3275–3279.
34. Ja ¨ger,M., Polborn,K. and Steglich,W. (1995) On-site modification of
oligopeptides: Conversion of seryl into (exo)-2-azabicyclo[2.2.1]hept-5-
ene-3-carbonyl residues. Tetrahedron Lett., 36, 861–864.
35. Pozsgay,V., Vieira,N.E. and Yergey,A. (2002) A method for
bioconjugation of carbohydrates using Diels-Alder cycloaddition.
Org. Lett., 4, 3191–3194.
36. Latham-Timmons,H.A., Wolter,A., Roach,J.S., Giare,R. and Leuck,M.
(2003)Novelmethodforthecovalentimmobilizationofoligonucleotides
via Diels-Alder bioconjugation. Nucleosides Nucleotides Nucleic Acids,
22, 1495–1497.
37. Seelig,B. and Ja ¨schke,A. (1997) Site-specific modification of
enzymatically synthesized RNA: transcription initiation and Diels-Alder
reaction. Tetrahedron Lett., 38, 7729–7732.
38. Fruk,L.,Grondin,A.,Smith,W.E.andGraham,D.(2002)Anewapproach
to oligonucleotide labelling using Diels-Alder cycloadditions and
detection by SERRS. Chem. Commun., 18, 2100–2101.
39. Graham,D., Grondin,A., McHugh,C., Fruk,L. and Smith,W.E. (2002)
InternallabellingofoligonucleotideprobesbyDiels-Aldercycloaddition.
Tetrahedron Lett., 43, 4785–4788.
40. Hill,K.W., Taunton-Rigby,J., Carter,J.D., Kropp,E., Vagle,K.,
Pieken,W., McGee,D.P., Husar,G.M., Leuck,M., Anziano,D.J. and
Sebesta,D.P. (2001) Diels-Alder bioconjugation of diene-modified
oligonucleotides. J. Org. Chem., 66, 5352–5358.
41. Hausch,F.andJa ¨schke,A.(2000)MultifunctionalDNAconjugatesforthe
in vitro selection of new catalysts. Nucleic Acids Res., 28, e35.
42. Tona,R. and Ha ¨ner,R. (2005) Synthesis and bioconjugation of
diene-modified oligonucleotides. Bioconjug. Chem., 16, 837–842.
43. Miller,C.A. and Batey,R.A. (2004) Hetero Diels-Alder reactions of
nitrosoamidines: An efficient method for the synthesis of functionalized
guanidines. Org. Lett., 6, 699–702.
44. Rink,H. (1987) Solid-phase synthesis of protected peptide fragments
using a trialkoxy-diphenyl-methylester resin. Tetrahedron Lett., 28,
3787–3790.
45. Barlos,K.,Chatzi,O.,Gatos,D.andStavropoulos,G.(1991)2-Chlorotrityl
chloride resin. Studies on anchoring of Fmoc-amino acids and peptide
cleavage. Int. J. Peptide Protein Res., 37, 513–520.
46. Ikeda,Y., Kawahara,S., Yoshinari,K., Fujita,S. and Taira,K. (2005)
Specific 30-terminal modification of DNA with a novel
nucleoside analogue that allows a covalent linkage of a nuclear
localizationsignalandenhancementofDNAstability.ChemBioChem.,6,
297–303.
47. Fields,G.B.andNoble,R.L.(1990)Solidphasepeptidesynthesisutilizing
9-fluorenylmethoxycarbonyl amino acids. Int. J. Peptide Protein Res.,
35, 161–214.
48. Carpino,L.A., Shroff,H., Triolo,S.A., Mansour,E., Wenschuh,H. and
Albericio,F. (1993) 2,2,4,6,7-Pentamethyldihydrobenzofuran-5-sulfonyl
group (Pbf) as arginine side-chain protectant. Tetrahedron Lett., 34,
7829–7832.
49. Beaucage,S.L. and Iyer,R.P. (1992) Advances in the synthesis of
oligonucleotides by the phosphoramidite approach. Tetrahedron, 48,
2223–2311.
50. Eritja,R., Pons,A., Escarceller,M., Giralt,E. and Albericio,F.
(1991) Synthesis of defined peptide–oligonucleotide hybrids
containing a nuclear transport signal sequence. Tetrahedron, 47,
4113–4120.
51. Gregory,J.D. (1955) The stability of N-ethylmaleimide and its reaction
with sulfhydryl groups. J. Am. Chem. Soc., 77, 3922–3923.
PAGE 9 OF 9 Nucleic Acids Research, 2006, Vol. 34, No. 3 e24